
A Winning Bid
Founded in 1998, Emergent BioSolutions has gone on to become a multinational biopharma company – despite working in some difficult therapeutic areas, including biodefense.

Founded in 1998, Emergent BioSolutions has gone on to become a multinational biopharma company – despite working in some difficult therapeutic areas, including biodefense.
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
Jim Jackson is Chief Scientific Officer at Emergent BioSolutions.
False
False
February 3, 2025
4 min read
With new cases of avian influenza appearing, what does this mean for global health and what are drug developers doing about it?
April 1, 2025
3 min read
Resignation letter states: “truth and transparency” around vaccines are not desired by Health Secretary RJK Jr. “Rather he wishes subservient confirmation of his misinformation and lies.”
April 10, 2025
2 min read
Studies have suggested that the RZV shingles vaccine can lower the risk of dementia; GSK is now investigating further
February 6, 2025
2 min read
Senate committee votes in favor of the nomination; full Senate vote will be next